Literature DB >> 12872360

Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women.

Laura Liberman1, Elizabeth A Morris, Catherine L Benton, Andrea F Abramson, D David Dershaw.   

Abstract

BACKGROUND: The purpose of the current study was to determine the frequency of 'probably benign' interpretations at breast magnetic resonance (MR) imaging screening of high-risk women and the frequency of subsequent malignancy in these women.
METHODS: The authors performed a retrospective review of the records of 367 asymptomatic women with normal mammograms who had a high risk of developing breast cancer and whose first breast MR imaging screening examinations occurred during a 2-year period. The number of "probably benign" interpretations was determined, and follow-up data were obtained.
RESULTS: A "probably benign" interpretation was given to 89 (24%) of 367 women. Follow-up MR imaging was performed for 70 (79%) of 89 women, with a median follow-up time of 11 months (range, 1-24 months). Twenty women subsequently underwent biopsy at a median of 9 months (range, 1-18 months) after MR imaging, due to progression on follow-up MR imaging (n=14) or for other reasons (n=6). Malignancies were found in 9 women, constituting 45% of the 20 women who underwent biopsy and 10% of the 89 women with probably benign lesions. In 6 of the 9 women who developed malignant disease (7% of the 89 women in the study), the malignancy was detected by follow-up MR imaging of an area that previously was interpreted as probably benign. Tumor histology was ductal carcinoma in situ (DCIS) in five patients and infiltrating ductal carcinoma in four.
CONCLUSIONS: A "probably benign" interpretation was given to 24% of high-risk women at their first breast MR imaging screening examination. In 7-10% of women with "probably benign" interpretations, malignant disease subsequently developed in an area initially judged to be probably benign; of these malignancies, more than half were DCIS, and more than half were detected by MR imaging only. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2003        PMID: 12872360     DOI: 10.1002/cncr.11491

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.

Authors:  M D Dorrius; R M Pijnappel; M C van der Weide Jansen; L Jansen; P Kappert; M Oudkerk; P E Sijens
Journal:  Eur Radiol       Date:  2011-11-11       Impact factor: 5.315

2.  Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Authors:  Susan P Weinstein; Lucy G Hanna; Constantine Gatsonis; Mitchell D Schnall; Mark A Rosen; Constance D Lehman
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy.

Authors:  Amy Lynn Conners; Carrie B Hruska; Cindy L Tortorelli; Robert W Maxwell; Deborah J Rhodes; Judy C Boughey; Wendie A Berg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06       Impact factor: 9.236

4.  The clinical value of bilateral breast MR imaging: is it worth performing on patients showing suspicious microcalcifications on mammography?

Authors:  Ayano Akita; Akihiro Tanimoto; Hiromitsu Jinno; Kaori Kameyama; Sachio Kuribayashi
Journal:  Eur Radiol       Date:  2009-04-07       Impact factor: 5.315

5.  Imaging studies for the early detection of breast cancer.

Authors:  Sylvia H Heywang-Köbrunner; Ingrid Schreer; Walter Heindel; Alexander Katalinic
Journal:  Dtsch Arztebl Int       Date:  2008-08-04       Impact factor: 5.594

6.  Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI.

Authors:  Bethany L Niell; Sara C Gavenonis; Tina Motazedi; Jessica Cott Chubiz; Elkan P Halpern; Elizabeth A Rafferty; Janie M Lee
Journal:  J Am Coll Radiol       Date:  2014-04-29       Impact factor: 5.532

Review 7.  BI-RADS 3 Assessment on MRI: A Lesion-Based Review for Breast Radiologists.

Authors:  Derek L Nguyen; Kelly S Myers; Eniola Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Emily B Ambinder
Journal:  J Breast Imaging       Date:  2022-06-28

Review 8.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  Breast cancer prevention in women with a BRCA1 or BRCA2 mutation.

Authors:  Kelly A Metcalfe; Steven A Narod
Journal:  Open Med       Date:  2007-12-18

10.  MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy.

Authors:  Carla Meeuwis; Jeroen Veltman; Hester N van Hall; Roel D M Mus; Carla Boetes; Jelle O Barentsz; Ritse M Mann
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.